Projects

Our experts are involved in building a range of bioinformatics resources for the Australian research community and making connections with global developments also. Other users are also making their mark in life sciences computing, as seen here.

Featured Projects

project

Australian Bioinformatics Commons

Over the past three years several NCRIS-funded projects have brought together research...find out more

project

The Australian Environmental Microbiome Research Data Cloud

In March 2018 we started work on the Australian Environmental Microbiome Research Data Cloud...find out more

project

Australian Genomics Health Alliance (Australian Genomics)

Melbourne Bioinformatics is one of 80 partners across Australia and internationally who are...find out more

project

Melbourne Genomics Health Alliance (Melbourne Genomics)

A Dutch study published in Genetics in Medicine on 4 February 2016 applies a cost analysis to the...find out more

project

Pan Prostate Genomics Consortium (PPGC)

Many groups around the world have generated Whole Genome DNA Sequence (WGS) data. To co-ordinate...find out more

project

Human Genomics Group

The Human Genomics Group is focused on enabling medical breakthroughs via new and cutting-edge...find out more

project

EMBL-ABR: Melbourne Bioinformatics Node

Melbourne Bioinformatics, as a high-end computing facility and a team of, now, 35 experts who are...find out more

project

EMBL Australia Bioinformatics Resource (EMBL-ABR)

EMBL-ABR aims to: increase Australia’s capacity to collect, integrate, analyse, exploit, share...find out more

project

Microbial Genomics Group

The Microbial Genomics Group contributes specialist expertise and leadership to national...find out more

project

Genomics Virtual Laboratory

Over ten years after the sequencing of the human genome, in 2013 the National eResearch...find out more

Other

Users on our systems work on a range of projects across the life sciences. Current highlights from some high profile researchers and their projects include:

December 2017
Well covered in the media in December was the publication in Nature Ecology & Evolution of the genome of the extinct Tasmanian tiger or thylacine. The research was led by Assoc Prof Andrew Pask from the School of BioSciences, The University of Melbourne, Victoria, Australia, with collaborators from Museums Victoria; the Institute of Experimental Pathology (ZMBE), University of Münster, Germany; the Australian Centre for Ancient DNA, University of Adelaide, South Australia; and, the Institute for Systems Genomics and Department of Molecular and Cell Biology, University of Connecticut, USA.

"The thylacine and the dog [or wolf] is the closest example of convergent evolution that we’ve ever seen measured between any two species", said Assoc Prof Pask. "When two animals that are not closely related evolved to look the same – that is really astounding."

The team's research data on unique Australian marsupials is of interest to the global life sciences research community and we hope that our involvement in the EMBL-ABR network can how help to make it more readily accessible.

Full story - https://pursuit.unimelb.edu.au/articles/secrets-from-beyond-extinction-the-tasmanian-tiger.

March 2017
Professor Tony Burkitt, Research Director of Bionic Vision Australia (BVA) and Professor of Engineering at the University of Melbourne, has been using our systems to examine the effect of electrical stimulation upon the neurons in the retina, with the aim of developing improved vision processing algorithms for retinal implants. Over 2016 this research program had a number of important achievements, mostly in the development of more refined computational models and new signal processing techniques.

Earlier this year the commercial arm of BVA, Bionic Vision Technologies, announced the commercialisation of the first generation of its technology and it will be ongoing modelling and refining of techniques which will contribute further to BVA’s outcomes. Prof Burkitt said, “It's great to see this technology transitioning into clinical and commercial use, and we're excited about what the future holds for this area!”

Read the news announcement here: http://bionicvis.com/wp-content/uploads/2017/04/03APR2017_BVT-media-release.pdf